Volume 15 - Issue 6 - June 2007
Column
Practice Pearls
09/04/2008
At some point in the dermatology practice lifecycle, there will inevitably arise this thought: I wonder what a practice consultant would say about this (insert question)?
Practice Performance Issues
It may be during a period of...
At some point in the dermatology practice lifecycle, there will inevitably arise this thought: I wonder what a practice consultant would say about this (insert question)?
Practice Performance Issues
It may be during a period of...
At some point in the dermatology...
09/04/2008
The Dermatologist
Spotlight
09/04/2008
Dr. Danby was raised in Kingston, Ontario, where he also completed all of his education, graduating with an M.D. degree from Queen’s University in 1967. He did his dermatology residency at the University of Toronto, finishing as chief...
Dr. Danby was raised in Kingston, Ontario, where he also completed all of his education, graduating with an M.D. degree from Queen’s University in 1967. He did his dermatology residency at the University of Toronto, finishing as chief...
Dr. Danby was raised in...
09/04/2008
The Dermatologist
Chief Medical Editor Message
09/04/2008
Does the thought of the Center for Medicare & Medicaid Services’ (CMS) new Physician Quality Reporting Initiative (PQRI) — or “Pay for Performance” as it has often been referred to — cause a pit in your stomach? If so, then you’re not...
Does the thought of the Center for Medicare & Medicaid Services’ (CMS) new Physician Quality Reporting Initiative (PQRI) — or “Pay for Performance” as it has often been referred to — cause a pit in your stomach? If so, then you’re not...
Does the thought of the Center...
09/04/2008
The Dermatologist
Department
Cosmetic Clinic
09/04/2008
At long last, the FDA finally approved Perlane last month. (Actually it should have been approved years ago.) Its introduction into the filler market is significant for a variety of reasons, and it behooves injectors to become familiar with...
At long last, the FDA finally approved Perlane last month. (Actually it should have been approved years ago.) Its introduction into the filler market is significant for a variety of reasons, and it behooves injectors to become familiar with...
At long last, the FDA finally...
09/04/2008
The Dermatologist
Allergen Focus
09/04/2008
In 1997 the Food and Drug Administration gave indication to the Thin-layer Rapid Use Epicutaneous (T.R.U.E.) test for use as a valuable, first-line screening tool in the diagnosis of allergic contact dermatitis (ACD). Many dermatologists and...
In 1997 the Food and Drug Administration gave indication to the Thin-layer Rapid Use Epicutaneous (T.R.U.E.) test for use as a valuable, first-line screening tool in the diagnosis of allergic contact dermatitis (ACD). Many dermatologists and...
In 1997 the Food and Drug...
09/04/2008
The Dermatologist
Derm Dx
09/04/2008
A 9-month-old female infant of Hispanic origin was referred to the clinic for evaluation of skin lesions persisting since birth.
A 9-month-old female infant of Hispanic origin was referred to the clinic for evaluation of skin lesions persisting since birth.
A 9-month-old female infant of...
09/04/2008
The Dermatologist
09/04/2008
DERMAL FILLERS
With so many choices, selecting the appropriate filler, or fillers, for our patients can pose challenges. Of the three dermal fillers evaluated in this article, two only very recently received clearance from the FDA —...
DERMAL FILLERS
With so many choices, selecting the appropriate filler, or fillers, for our patients can pose challenges. Of the three dermal fillers evaluated in this article, two only very recently received clearance from the FDA —...
DERMAL FILLERS
With so many...
09/04/2008
The Dermatologist
Issues in Dermatology
09/04/2008
Undoubtedly, But Patients` Interests Come FirstBy Gary Goldenberg, M.D. A recent study in the Journal of Medical Ethics found that 33% of responding obstetrics/gynecology physicians thought that their decision to prescribe a drug would...
Undoubtedly, But Patients` Interests Come FirstBy Gary Goldenberg, M.D. A recent study in the Journal of Medical Ethics found that 33% of responding obstetrics/gynecology physicians thought that their decision to prescribe a drug would...
Undoubtedly, But Patients`...
09/04/2008
The Dermatologist
09/04/2008
The mainstay therapeutics for the management for atopic dermatitis have not changed significantly over the last 50 years. These consist of traditional emollients such as petrolatum and various forms of topical steroids for flare-ups...
The mainstay therapeutics for the management for atopic dermatitis have not changed significantly over the last 50 years. These consist of traditional emollients such as petrolatum and various forms of topical steroids for flare-ups...
The mainstay...
09/04/2008
The Dermatologist
09/04/2008
When Paul Storrs, M.D., delivered a recent presentation to members of the University of Illinois-Chicago’s dermatology department on the Centers for Medicare & Medicaid Services’ (CMS) new Physician Quality Reporting...
When Paul Storrs, M.D., delivered a recent presentation to members of the University of Illinois-Chicago’s dermatology department on the Centers for Medicare & Medicaid Services’ (CMS) new Physician Quality Reporting...
When Paul Storrs, M.D.,...
09/04/2008
The Dermatologist
